DR. JOSEPH MARION BLANDFORD JR., M.D.

Plain English
This study focused on creating effective ways to communicate the message "Undetectable equals Untransmittable" (U=U) about HIV in South Africa. Researchers found that there was low awareness and some skepticism about U=U, especially in Africa, so they developed an intervention called "Undetectable and You" to help educate patients. This intervention includes personal stories from people living with HIV, delivered through an app, to improve understanding and encourage adherence to treatment. Who this helps: This benefits patients living with HIV, their partners, and healthcare providers.

Plain English
This study looked at how the global HIV response targets, known as the 95-95-95 goals, may not apply equally across different regions in Eastern and Southern Africa, where the number of people living with HIV varies greatly. Researchers found that areas with higher HIV rates will still have many people who are not effectively treated, which can lead to more health issues and continued transmission of the virus. This matters because relying solely on these uniform targets can misdirect resources and prevent fair progress in controlling the HIV epidemic in diverse regions. Who this helps: This helps public health officials and policymakers improve HIV treatment strategies and allocate resources more effectively.

Plain English
This study looked at the health benefits and costs of allowing more people with HIV to start treatment earlier, specifically those with higher CD4 counts than previous guidelines suggested. The research found that expanding eligibility to include adults with CD4 counts of 500 cells per microliter or less could save money and improve health outcomes in countries like South Africa and Zambia, with costs per health benefit ranging from $237 to $749 for each year of healthy life gained. This is important because it helps decision-makers understand that treating more people sooner can be both effective and cost-efficient in fighting HIV. Who this helps: Patients with HIV and healthcare providers.

Plain English
This study looked at a rare brain condition called perimesencephalic subarachnoid hemorrhage, which can sometimes occur after a person practices breath-holding while swimming. The researchers found that a patient experienced this condition during "hypoxic training," indicating that pressure in the veins might lead to such bleeding in the brain. This discovery underscores the need for doctors to be cautious as hypoxic training becomes more popular among athletes. Who this helps: This benefits athletes and coaches who practice or promote hypoxic training.

Plain English
This study looked at the health benefits and costs of starting HIV treatment (antiretroviral therapy or ART) earlier and making it available to more people in four countries: South Africa, Zambia, India, and Vietnam. Researchers found that expanding ART eligibility to include people with higher CD4 cell counts—up to 500 cells/µL—was very cost-effective, with costs per health benefit (measured in DALYs) ranging from $237 to $1691 in South Africa and from $131 to $749 in Zambia. These results suggest that making treatment more accessible could significantly improve health outcomes while being a wise use of healthcare funds in low- and middle-income countries. Who this helps: This benefits HIV patients and healthcare decision-makers in resource-limited settings.

Plain English
This study examined how improving health systems influences the effectiveness of HIV services and found that strong health systems are essential for successful HIV treatment programs. It emphasized four important actions: aligning funding with national health strategies, investing in training and keeping skilled healthcare workers, exploring new financing options, and updating service delivery models based on the latest HIV treatment research. These improvements are crucial for making HIV care more sustainable and effective. Who this helps: This helps patients and healthcare providers involved in managing and treating HIV.